Biomed Laboratory

Biomed Lublin is a prominent Polish biopharmaceutical company specializing in the research, development, and manufacture of vaccines, serums, and blood-derived products. Established in 1944 and headquartered in Lublin, the company is a leading producer of the BCG vaccine for tuberculosis and Onko BCG for the treatment of superficial bladder cancer. Their diverse portfolio also features proteolytic enzymes like Distreptaza and probiotics such as Lakcid. Biomed Lublin is publicly traded on the Warsaw Stock Exchange and operates GMP-certified facilities to serve both domestic and international markets. The company is particularly noted for its expertise in immunotherapy and its efforts in developing immunoglobulin therapies, including significant research into treatments for SARS-CoV-2.